Back to search

Article

Mirror Symmetry Drug Design (MSDD): A Parity-Inversion Framework for Generative De Novo Design of Proteolytically Stable Dual-Targeting D-Peptides against Bcl-2 and Mcl-1

2026-08-10

Abstract excerpt

<title>Abstract</title> <p>We report the Mirror Symmetry Drug Design (MSDD) framework, a novel computational method for the de novo generative design of proteolytically stable D-peptide inhibitors targeting protein--protein interactions (PPIs) that are inaccessible to current generative structural AI. State-of-the-art flow-matching models---trained on a Protein Data Bank composed of $>$99.9\% L-amino acids---exhi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9a25bc9c-15d7-52b7-bdfb-e15760a51fbc
DOI
10.21203/rs.3.rs-10477553/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mirror Symmetry Drug Design (MSDD): A Parity-Inversion Framework for Generative De Novo Design of Proteolytically Stable Dual-Targeting D-Peptides against Bcl-2 and Mcl-1DOI 10.21203/rs.3.rs-10477553/v1
Select a neighboring publication to make it the new centre.